T1	Outcomes 563 578	serum androgens
T2	Outcomes 1337 1371	levels of intraprostatic androgens
T3	Outcomes 1418 1470	primary end point (dihydrotestosterone/testosterone)
T4	Outcomes 1703 1738	low incidence of complete responses
T5	Outcomes 1743 1767	minimal residual disease
T6	Outcomes 1870 1897	suppresses tissue androgens
T7	Outcomes 1943 1976	intratumoral androgen suppression
